Clinical trial Recruiting at 1 site Observational Ages 0 Months to 12 Months

Comparing diaphragm function measurement techniques in infants on respiratory support

Official title: PRospective Observational Study Comparing Electromyography of the Diaphragm With Ultrasound in Neonates and Children With REspiratory Support: the PROCEDURES Study

Run by Leiden University Medical Center · NCT05965830 · Data updated 2026-11-12

This study is testing two ways to measure how well the diaphragm works in infants on breathing support to see which method is more reliable for checking their readiness to breathe on their own.

Quick facts

Study typeObservational
Ages0 Months to 12 Months
SexAll
Enrollment50 (estimated)
SponsorLeiden University Medical Center
Academic / other
Locations1 site (Leiden)
StatusRecruiting
StartedNovember 25, 2023
Main results expectedOctober 2025
Study endsNovember 2025
Registry record updatedMarch 18, 2025
Trial IDNCT05965830 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are infants and children aged 0-12 months who are admitted to the PICU and require invasive respiratory support.

Probably not a fit

Patients with unilateral diaphragm paresis, congenital malformations, or those deemed too vulnerable by their physician may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the relationship between transcutaneous diaphragm electromyography (dEMG) and diaphragm ultrasound (dUS) in infants and children under 12 months receiving invasive respiratory support in the Pediatric Intensive Care Unit (PICU). The study will involve simultaneous monitoring of diaphragm function using both techniques during extubation readiness tests. Clinically stable patients who meet specific inclusion criteria will be enrolled, and measurements will be taken to assess diaphragm muscle function. The goal is to establish a reliable method for evaluating diaphragm performance in this vulnerable population.

Why it matters

Potential benefit: If successful, this study could lead to improved assessment and management of respiratory insufficiency in neonates and children.

How similar studies have gone: While the use of dEMG and dUS is promising, this specific comparative approach in the PICU population is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 0 - 12 months of age at the moment of inclusion and born ≥ 37 weeks gestational age.
* Specific patients cohort PICU:

pediatric patients with invasive respiratory support comply with the extubation readiness test (ERT) criteria

* No spontaneous breathing for the duration of the assessment
* Written parenteral informed consent (IC)
* A patient can only participate once

Exclusion Criteria:

* Unilateral diaphragm paresis diagnosed by ultrasound
* Congenital malformations not compatible with dEMG
* Need of cardiac pacing
* Congenital muscle atrophy disorder
* Clinical instability requiring frequent interventions by the nursing staff that may interfere with the measurements
* The attending physician considers the patient to be too vulnerable to participate in the study

Where it's running

  • Pediatric Intensive Care Unit
    Leiden, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.